ストックスクリーナーアプリを入手
4.56
4.00%
-0.19
アフターアワーズ：
4.56
前日終値:
$4.75
開ける：
$4.71
24時間の取引高:
841.06K
Relative Volume:
1.38
時価総額：
$441.77M
収益：
-
当期純損益:
$-238.77M
株価収益率:
-0.1701
EPS:
-26.808
ネットキャッシュフロー:
$-216.62M
1週間 パフォーマンス:
-5.20%
1か月 パフォーマンス:
+13.43%
6か月 パフォーマンス:
-0.65%
1年 パフォーマンス:
-59.68%
1日の値動き範囲:
$4.385
$4.75
1週間の範囲:
$4.385
$4.88
52週間の値動き範囲:
$2.7601
$13.00
Alumis Inc Stock (ALMS) Company Profile
ALMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
4.56 | 494.31M | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-25 | 開始されました | Wells Fargo | Overweight |
| 2025-06-10 | 再開されました | Guggenheim | Buy |
| 2025-01-30 | 開始されました | Oppenheimer | Outperform |
| 2024-10-31 | 開始されました | Robert W. Baird | Outperform |
| 2024-10-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-07-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-07-23 | 開始されました | Guggenheim | Buy |
| 2024-07-23 | 開始されました | Leerink Partners | Outperform |
| 2024-07-23 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Alumis Inc (ALMS) 最新ニュース
Will Alumis Inc. continue its uptrendQuarterly Market Review & Stepwise Trade Execution Plans - newser.com
Will Alumis Inc. stock benefit from upcoming earnings reportsJuly 2025 Review & Technical Buy Zone Confirmation - newser.com
Why Alumis Inc. stock is recommended by analystsJuly 2025 Macro Moves & Entry Point Confirmation Signals - newser.com
Is a relief rally coming for Alumis Inc. holdersGlobal Markets & Free High Return Stock Watch Alerts - newser.com
Will Alumis Inc. stock remain a Wall Street favoritePortfolio Risk Summary & High Win Rate Trade Tips - newser.com
Real time scanner hits for Alumis Inc. explained2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Will Alumis Inc. stock benefit from sector rotationJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Momentum divergence signals in Alumis Inc. chart2025 Short Interest & Daily Profit Focused Screening - newser.com
Is Alumis Inc. a candidate for recovery playQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
How to manage a losing position in Alumis Inc.Earnings Growth Report & Low Risk Entry Point Guides - newser.com
Analyzing drawdowns of Alumis Inc. with statistical toolsJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
Is Alumis Inc. stock positioned for long term growthJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Pattern recognition hints at Alumis Inc. upsideJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Will Alumis Inc. outperform the marketMarket Movers & Free Real-Time Volume Trigger Notifications - newser.com
Tools to assess Alumis Inc.’s risk profileJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
Chart based exit strategy for Alumis Inc.Earnings Overview Summary & AI Driven Stock Movement Reports - newser.com
Sentiment Watch: Will Alumis Inc. stock outperform value stocksJuly 2025 Opening Moves & Free Technical Confirmation Trade Alerts - Fundação Cultural do Pará
How sustainable is Alumis Inc. stock dividend payoutEarnings Overview Summary & High Accuracy Trade Signal Alerts - Fundação Cultural do Pará
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment - TipRanks
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer for Hepatic Impairment Treatment? - TipRanks
Alumis Inc (ALMS) 財務データ
収益
当期純利益
現金流量
EPS
Alumis Inc (ALMS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Tananbaum James B. | Director |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| Foresite Labs, LLC | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
| Foresite Labs, LLC | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| Foresite Capital Management VI | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
| Foresite Capital Management VI | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| AKKARAJU SRINIVAS | Director |
May 05 '25 |
Buy |
4.67 |
160,370 |
749,676 |
3,586,788 |
| AKKARAJU SRINIVAS | Director |
May 02 '25 |
Buy |
4.55 |
159,920 |
727,636 |
3,426,418 |
| Colowick Alan | Director |
Apr 01 '25 |
Buy |
6.97 |
16,104 |
112,309 |
16,104 |
| Colowick Alan | Director |
Apr 02 '25 |
Buy |
7.49 |
2,300 |
17,235 |
18,404 |
| Babler Martin | President, CEO and Chairman |
Apr 01 '25 |
Buy |
6.44 |
15,650 |
100,733 |
106,454 |
0.64%
0.35%
大文字化:
|
ボリューム (24 時間):